Peter Schiff, a longtime Bitcoin critic, advises selling both Bitcoin and Strategy's stock (MSTR) following Strategy's recent sales of Bitcoin to raise cash. Strategy, led by Michael Saylor, has been offloading Bitcoin at a loss to increase its cash reserves and repurchase preferred stock as part of a new monetization plan. Despite these sell-offs, some analysts view the gradual deleveraging as positive for Bitcoin's long-term health. Meanwhile, hedge funds have turned net long on Bitcoin futures, signaling potential bullish momentum. The situation remains uncertain as Strategy continues to sell Bitcoin while market reactions fluctuate.
Grail's stock surged 55% in one week following a positive FDA advisory committee vote on its Galleri multi-cancer early detection test, which was deemed safe and beneficial. Analyst Kyle Mikson raised the price target from $80 to $150, reflecting str...
Roblox stock fell 6% following Jefferies' downgrade to Underperform and a price target cut to $38, citing concerns over overly optimistic bookings outlook and slower user growth in the US and Canada. This downgrade contrasts with steady performance i...
Geely Holding Group has acquired a 30% stake in Nio Power, the battery swapping and charging unit of Nio, valuing the business at about RMB16 billion. This investment marks a significant external validation of Nio's battery swapping network, a key as...
CoreWeave reported strong Q2 results with significant scale and margin improvements, supported by a $104.2 billion backlog driven by demand from hyperscalers exceeding supply. The company raised its 2026 revenue guidance to $12.4–$13.2 billion, expec...
Tiziana Life Sciences has dosed the first three patients in a Phase 2a trial testing foralumab, a nasal spray antibody, for treating early-stage ALS. The Healey ALS MyMatch BANYAN trial will enroll 44 patients to evaluate safety, tolerability, and im...
